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Aim To identify predictors of bacteremia in critically ill pa-
tients, to evaluate the impact of blood cultures on the out-
come, and to define conditions for breakthrough bacter-
emia despite concurrent antibiotic treatment. 
Methods A descriptive retrospective study was performed 
over a two-year period (2007-2008) in the medico-surgical 
Intensive Care Unit (ICU) of the San Giovanni Hospital in 
Bellinzona, Switzerland.
Results Forty-five out of 231 patients (19.5%) had posi-
tive blood cultures. Predictors of positive blood cultures 
were  elevated  procalcitonin  levels  (>2  µg/L,  P < 0.001), 
higher severity scores (Simplified Acute Physiology Score 
II>43, P = 0.014; Sequential Organ Failure Assessment >4.0, 
P < 0.001), and liver failure (P = 0.028). Patients with bacte-
remia had longer hospital stays (31 vs 21 days, P = 0.058), 
but their mortality was not different from patients without 
bacteremia. Fever (t > 38.5°C) only showed a trend toward 
a higher rate of blood culture positivity (P = 0.053). The rate 
of positive blood cultures was not affected by concurrent 
antibiotic therapy.
Conclusions The prediction of positive blood culture re-
sults still remains a very difficult task. In our analysis, blood 
cultures were positive in 20% of ICU patients whose blood 
was cultured, and positive findings increased with elevated 
procalcitonin levels, liver failure, and higher severity scores. 
Blood cultures drawn >4 days after the start of antibiotic 
therapy and >5 days after surgery could detect pathogens 
responsible for a new infection complication.
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Sepsis is a common and threatening occurrence in the in-
tensive care unit (ICU), where up to 35% of patients de-
velop such a condition at some point during their stay (1). 
The associated mortality is 27% but exceeds 50% in cases 
of septic shock (1,2).
Blood  cultures  represent  an  important  diagnostic  tool, 
though they detect bacteremia in only about 50% of pa-
tients who are clinically suspected of having sepsis (2), with 
an even lower rate of positivity when drawn in the presence 
of ongoing antibiotic therapy (3-6).The presence of a blood 
pathogen represents a negative prognostic factor (7), but 
the isolation of such pathogen is crucial for verifying the 
appropriateness of antibiotic therapy, which is known to re-
duce morbidity and mortality (8,9). Furthermore, cultures of 
specific sites of suspected infection do not reliably predict 
the findings of blood cultures (10). Conversely, false-posi-
tive results from bacterial contaminants may lead to unnec-
essary antibiotic therapy, longer hospital stays (11), and se-
lection of resistant microorganisms (12,13). 
Most physicians have a low threshold for ordering blood 
cultures, regardless of concurrent antibiotics, whenever a 
patient develops a new fever. The same usually occurs in 
the case of a clinical decline that is potentially caused by in-
fection or of laboratory signs of a worsening inflammatory 
state, bearing in mind that correlations are lacking between 
degree of fever, leukocytosis, and bacteremia (14-17).
We  conducted  a  retrospective  study  in  our  multidisci-
plinary ICU in Switzerland to investigate the rate of posi-
tive blood cultures drawn from our ICU patients in case of 
temperature over 38.5°C and/or clinical decline with a con-
comitant worsening inflammatory state. We aimed to de-
termine the influence of concurrent antibiotics, to identify 
predictors of bacteremia and conditions for breakthrough 
bacteremia despite antibiotics, and to compare our find-
ings with those published mainly by US and Canadian uni-
versity hospitals.
Methods
Setting
This descriptive retrospective study was performed in the 
ICU of the San Giovanni Hospital in Bellinzona, Switzerland. 
This is an eight-bed multidisciplinary teaching structure 
with about 750 adult admissions per year from internal 
medicine, oncology, general surgery (no cardiac surgery or 
organ transplantations), urology, orthopedic surgery, ear, 
nose, and throat, and gynecology. Considering the retro-
spective, non-interventional design of this quality assur-
ance study, no informed consent was required by the Can-
tonal Ethics Committee.
Study population, data collection and definitions
Patients aged ≥16 years who had at least one blood cul-
ture drawn in the ICU or within 24 hours before admis-
sion were retrospectively identified by our microbiology 
laboratory. Hospital charts were reviewed to collect per-
sonal data (age, sex), diagnosis at admission, the Simplified 
Acute Physiology Score (SAPS) II (at 24 hours from ICU ad-
mission) and Simplified Organ Failure Assessment (SOFA, 
computed on the day of sampling) (18,19), and lengths of 
stay in the ICU and in the hospital (also considering pre- 
and  post-culture  values).  We  recorded  antibiotic  status 
(dividing samples into pre-antibiotic and antibiotic blood 
culture groups, with the latter drawn with concurrent an-
tibiotics), comorbidities (hepatic failure, active malignancy, 
diabetes mellitus), immunodeficiency (AIDS, immunosup-
pressive  drugs,  chemotherapy,  steroids),  and  conditions 
on the day of the sampling potentially associated with 
the outcomes of the exams (body temperature, laboratory 
tests, invasive mechanical ventilation, indwelling venous/
arterial or urinary catheters, surgical wounds). The number 
and timing of blood cultures, their results, interpretation, 
and data regarding antibiotic therapy administered before 
sampling were also obtained.
A blood culture was considered positive when it yielded 
Staphylococcus  aureus,  non-viridans  group  Streptococci 
(including group A or group B Streptococci), Enterococci, 
enteric gram-negative bacilli, Pseudomonas spp, Bacteroi-
des spp, or fungi. Bacteria like viridans group Streptococ-
ci,  coagulase-negative  Staphylococci,  Propionibacterium 
spp, Corynebacterium spp or Bacillus spp were considered 
pathogens (20) only if two separate blood cultures were 
positive and at least two SIRS criteria (21) were fulfilled. 
Otherwise, they were considered contaminants and blood 
cultures were not included in the bacteremic group.
Specimen collection and processing
Blood samples were collected by nurses following a ster-
ile  procedure  in  accordance  with  the  local  protocol:  20 
mL of blood was obtained for each blood culture, with 10 
mL inoculated into each aerobic and anaerobic bottle. At 
least one blood culture (one bottle for aerobic growth and 
one for anaerobic growth) was drawn. Samples were pro-
cessed by the Institute of Microbiology (Bellinzona) in a 
Bact/Alert 3D (bioMérieux SA, Marcy L’Etoile, France) au-
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bial growth was detected by continuously monitoring the 
CO2 production in the bottles. Identification of microorgan-
isms and antibiotic susceptibility testing were performed 
according to standard laboratory operating procedures.
Statistical analysis
Continuous  values  are  shown  as  means ± standard  de-
viations, and medians and ranges whenever the distribu-
tion was not normal. Categorical values were expressed as 
counts and percentages. To compare continuous values 
we used t test and Wilcoxon rank-sum test if the hypoth-
esis of normality was rejected and for categorical values 
we used χ2 tests. We also considered analyses for every 
unit of observation (series of blood cultures) to neutralize 
discrepancies between patients with different number of 
examined septic episodes and different number of blood 
cultures per septic episode. A series of blood cultures was 
defined as all blood cultures obtained from one patient on 
the same day. This served to identify potential predictors of 
bacteremia. If at least one blood culture was positive (ac-
cording to the previously mentioned criteria), the series 
was considered positive for bacteremia. The link between 
bacteremia and different factors was investigated with a 
logistic regression model, where age and presence of an-
tibiotic therapy were systematically incorporated into the 
model to reduce the effect of potential biases. All analyses 
were performed with Spotfire S+® 8.1 for Windows (TIBCO 
Software Inc. Palo Alto, CA, USA).
Results
Study population
From  1444  patients  admitted  to  the  ICU  from  January 
2007 to December 2008, 231 were eligible for the study 
(Figure 1), with 616 blood cultures and 310 series of blood 
cultures. There were 89 patients (39%) with 269 antibiotic 
blood cultures (44%) and 138 series of antibiotic blood cul-
tures (45%). The blood of most patients (79%) was cultured 
on one day.
Negative blood cultures were found in 186 patients (81%), 
with 23 contaminations, 107 of whom were not given con-
current antibiotic therapy and 79 were. Forty-five patients 
had at least one positive blood culture (31 patients with-
out and 14 patients with concurrent antibiotics), resulting 
in a true positive rate of 19.5% and an incidence of bacter-
emia of 3.1 per 100 ICU admissions. 
The  diagnosis  at  admission  most  frequently  associated 
with positive results (69%) was sepsis/septic shock (Table 
1; about 50% of patients with sepsis/septic shock had posi-
tive blood cultures). While the length of the ICU stay was 
unaffected by blood culture results, there was a trend to-
ward longer hospital stays in bacteremic patients (Table 
2). ICU and hospital mortality rates were 10% and 15%, re-
spectively, and were not affected by positive blood culture 
results.
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Link between bacteremia and other factors
Positive blood cultures were associated with higher se-
verity scores (SAPS II>43 at admission and SOFA score >4 
the day of sampling; cut-off levels were set at the median 
of the observations) and hepatic failure (Table 3). A pre-
dictive factor were also procalcitonin levels above 2 µg/L, 
while fever showed only a trend toward a positive correla-
tion. Fever higher than 38.5°C had a low positive predictive 
value (0.23; 95% confidence interval [CI], 0.14-0.33), while 
absence of fever had a higher predictive value (negative 
predictive value, 0.87; 95% CI, 0.81-0.91) without being dis-
criminating. Actually, afebrile bacteremia (Tmax ≤38.5°C) 
was identified in 13% of units of observation.
Factors that were not predictive of positive blood cultures 
were  age  (P = 0.063),  major  comorbidities  (endocarditis 
[P = 0.379], pneumonia [P = 0.771], malignancy [P = 0.483], 
diabetes  [P = 0.256]),  immunodepression  (chemotherapy 
[P = 0.599], immunosuppressive drugs [P = 0.139], steroids 
[P = 0.232]), and medical devices (central venous catheter 
[P = 0.508], urinary catheter [P = 0.139], drains [P = 0.829]). 
Indwelling  arterial  catheters  and  mechanical  ventilation 
were  actually  correlated  with  negative  blood  cultures 
(odds ratio, 0.45; P = 0.020, and odds ratio, 0.46; P = 0.045, 
respectively). Seventy-three patients received invasive me-
chanical ventilation (36 of whom had major infections at 
admittance), with 242 blood cultures (176 antibiotic blood 
cultures, 73%). Seven of these patients (10% of patients 
and 9% of series of blood cultures) had positive blood cul-
tures, independent of the length of mechanical ventilation 
(≤6 days vs >6 days, P = 0.101).
Positive blood cultures were not correlated with surgical 
wounds (P = 0.286). There were 36 surgical patients with 
38 pre-antibiotic (31.7%) and 82 antibiotic blood cultures 
(68.3%). All 20 patients who were sampled within the first 
three postoperative days had negative blood cultures. All 
4 patients with positive results had blood cultures drawn 
more than six days after surgery.
TABle 1. Characteristics of patients with negative and positive blood cultures*
No. (%) of patients
all (n = 231) negative (n = 186) positive (n = 45) P
Age, mean ±SD (years)   65 ± 16   64 ± 16 67 ± 12   0.583
Sex:
male 153 (66) 121 (65) 32 (71)   0.552
female   78 (34)   65 (35) 13 (29)
SAPS ii, mean ±SD   44.29 ± 19.78   42.44 ± 18.73 51.93 ± 21.75   0.007
Blood cultures performed, median (range)     2 (1-11)     2 (1-8)   2 (1-11) <0.001
Diagnosis:
sepsis/septic shock   63 (27)   32 (17) 31 (69) <0.001
non-septic shock   10 (4)     9 (5)   1 (2)   0.439
cardiovascular disease   35 (15)   30 (16)   5 (11)   0.400
cardiac arrest     5 (2)     5 (3)   0 (0)   0.266
respiratory disease   45 (19)   42 (23)   3 (7)   0.016
gastrointestinal disease     6 (3)     6 (3)   0 (0)   0.222 
neurological disease   18 (8)   15 (8)   3 (8)   0.754
trauma     8 (3)     8 (4)   0 (0)   0.157
surgery   25 (11)   23 (12)   2 (4)   0.205
psychiatric disease     3 (1)     3 (2)   0 (0)   0.391
others   13 (6)   13 (7)   0 (0)   0.070
*Abbreviations: SD – standard deviation; SAPS ii – Simplified Acute Physiology Score ii (18).
TABle 2. Outcomes of patients with negative and positive 
blood cultures
Patients
all 
(n = 231)
negative 
(n = 186)
positive 
(n = 45)
 P
length of stay in days, 
median (range):
intensive care unit   5 (1-125)  5 (1-125)   6 (2-46) 0.221
hospital 17 (2-194) 16 (2-136) 19 (2-194)0.058
hospital before blood culture  1 (0-64)   1 (0-26)   0 (0-64) 0.445
hospital after blood culture 14 (1-192) 13 (1-135) 17 (1-192) 0.117
Mortality
intensive care unit, n (%) 22 (10) 18 (10)   4 (9) 0.872
hospital, n (%) 35 (15) 28 (15)   7 (16) 0.933CLINICAL SCIENCE 34 Croat Med J. 2012;53:30-9
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Bacteremia showed only a trend toward correlation with 
ongoing antibiotic therapy (P = 0.058), with no significant 
impact of its length: patients with negative blood cultures 
were treated for a mean of 6.2 days and patients with pos-
itive blood cultures were treated for a mean of 5.3 days. 
Nevertheless, 96.1% of blood cultures drawn within the 
first 72 hours were negative, and 83.3% of positive blood 
cultures were drawn more than 4 days after the start of an-
tibiotic treatment. Bacteremic patients had a greater num-
ber of obtained blood cultures (Table 1) but also a greater 
number of series of blood cultures than non-bacteremic 
patients (1.7 for bacteremic patients and 1.2 for non-bacte-
remic patients, P = 0.009).
Microbiology analysis
Pathogens were isolated from antibiotic blood cultures in 
14 of 45 patients with positive blood cultures (Table 4). 
Gram-positive and Gram-negative bacteria were identi-
fied in the same proportions, and fungi were identified in 
three singular cases. Staphylococcus aureus was the only 
organism that grew in antibiotic blood cultures (two pa-
tients),  despite  normal  immune  status  and  adequate 
therapy (as assessed by in vitro testing) over four and five 
days, respectively. In four cases, while pre-antibiotic blood 
cultures remained sterile, we identified pathogens in an-
tibiotic blood cultures: coagulase-negative Staphylococ-
cus determining two catheter-related bloodstream infec-
tions (one from a peripheral venous line and one from a 
portacath); coagulase-negative Staphylococcus in a pa-
tient with superinfection of an aortic graft; and Enterococ-
cus faecium and Enterobacter aerogenes in a patient with 
tertiary peritonitis. Two patients had different pathogens 
isolated from their pre-antibiotic and antibiotic blood cul-
tures: Enterococcus faecium after a 7-day therapy for uro-
TABle 3. Potential predictors of bacteremia
Predictor Total
No. (%) of series 
of BCs (310)
No. (%) of series 
of BCs with bacteremia
Odds ratio 
(95% confidence interval)* P*
Antibiotic therapy:
yes 138 (45) 15 (11) 0.53 (0.27-1.04)   0.058
no 172 (55) 34 (20) 1
Age (years):
up to 55   87 (28)   8 (9) 1   0.063
56 to 65   64 (21) 17 (27) 3.33 (1.32-8.40)
66 to 75   87 (28) 12 (14) 1.55 (0.60-1.55)
≥76   72 (23) 12 (17) 1.77 (0.67-4.66)
Sequential Organ Failure Assessment (19):
>4 122 (39) 32 (26) 3.81 (1.95-7.44) <0.001
≤4 188 (61) 17 (9) 1
Simplified Acute Physiology Score ii (18):
>43 150 (48) 30 (20) 2.25 (1.16-4.38)   0.014
≤43 160 (52) 21 (12) 1
Hepatic failure   32 (10) 10 (31) 2.81 (1.15-6.86)   0.028
Temperature (°C):
>38.5   80 (26) 18 (22) 1.98 (1.00-3.94)   0.053
≤38.5 230 (74) 30 (13) 1
White blood cells (G/l)
>12 160 (52) 22 (14) 0.77 (0.40-1.45)   0.411
≤12 150 (48) 26 (17) 1
C-reactive protein (mg/l):†
>100 173 (57) 31 (18) 1.45 (0.76-2.80)   0.256
≤100 130 (43) 18 (14) 1
Procalcitonin (μg/l):‡
>2   53 (38) 15 (28) 9.68 (1.81-51.93) <0.001
0.5-2   40 (28)   2 (5) 1
<0.5   48 (34)   4 (8) 1.45 (0.23-9.35)
*Adjusted by age and presence or absence of antibiotic therapy. BC – blood cultures. 
†7 (2%) missing values. 
‡169 (55%) missing values.35 Previsdomini et al: Blood cultures in critically ill patients
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sepsis (previous strain: Escherichia coli) and Enterococcus 
faecium and Aerococcus viridans after a 3-day therapy for 
acute cholangitis (previous strains: Klebsiella oxytoca and 
Escherichia coli).
Discussion
Our results showed that blood cultures obtained as part 
of an “extended” infectious work-up in a general ICU pop-
ulation had a limited chance of identifying pathogens. 
This confirms previous data reported in large US/Cana-
dian tertiary hospitals (10,17,22,23). In our antibiotic-free 
population, 20% of the series of blood cultures was posi-
tive, and 11% was positive if obtained in the presence 
of a concurrent antibiotic therapy. Thus, only a trend to-
ward difference was detected based on the antibiotic 
status.
The overall incidence of bacteremia was 3.1 per 100 ICU 
admissions, a rate comparable with that reported in an 
adult ICU in a 25-year observation period (24). Our results 
support the common notion that bacteremia in ICU pa-
tients is difficult to predict. We confirmed the results of 
other studies (3,25) that showed that fever alone cannot 
be considered a solid predictor of bacteremia, as it could 
also be an expression of non-infectious inflammatory 
reactions. Conversely, an absence of fever was associ-
ated with a low rate of blood culture positivity but 
TABle 4. Pathogens isolated from blood
Organism
Patients with 
positive pre-
antibiotic BCs*
Patients with 
positive 
antibiotic BCs*
Concurrent
therapy
Duration 
of therapy 
(days)
Susceptibility to 
concurrent antibi-
otic therapy
Gram-positive bacteria (n = 25):
Staphylococcus aureus  4  3 amoxicillin/clavulanate
imipenem/cilastatin, vancomycin‡
amoxicillin/clavulanate, gentamycin
4
0¶
5,2
susceptible†
susceptible
susceptible†
Coagulase-negative 
Staphylococcus
 3  4 amoxicillin/clavulanate
amoxicillin/clavulanate
ceftriaxone
ceftriaxone, metronidazole
9
3
2
6,2
resistant
resistant
resistant
resistant
Streptococcus pneumoniae  3  0
Streptococcus bovis  1  0
Enterococcus spp  2  3 ceftriaxone, metronidazole§
amoxicillin/clavulanate
imipenem/cilastatinII
3
7
6
resistant
resistant
resistant
Aerococcus viridans  0  1 ceftriaxone, metronidazole§ 3 susceptible
Gram-positive anaerobic cocci  1  0
Gram-negative bacteria (n = 22):
Escherichia coli 12  1 amoxicillin/clavulanate, ciprofloxacin 0 susceptible
Enterobacter spp  1  1 imipenem/cilastatinII 6 susceptible
Klebsiella spp  3  1 amoxicillin/clavulanate 9 resistant
Citrobacter spp  2  0
Salmonella group E  1  0
Fungi (n = 3):
Candida glabrata  0  2 tazobactam/piperacillin, 
vancomycin, fluconazole
imipenem/cilastatin, fluconazole
11
 
11, 5
resistant
resistant
Candida pelliculosa  0  1 imipenem/cilastatin, vancomycin‡ 0 resistant
Total 33 17
*Pre-antibiotic denotes blood cultures (BC) drawn without concurrent antibiotic therapy. Antibiotic denotes BCs drawn with concurrent antibiotic 
therapy. For microorganisms identified in the antibiotic BC type, duration and susceptibility to concurrent therapy are reported.
†in two cases, we observed persistent Staphylococcus aureus infection despite adequate antibiotic therapy.
‡Staphylococcus aureus and Candida pelliculosa were isolated in the same BC.
§Enterococcus spp. and Aerococcus viridians were isolated in the same BC.
iiEnterococcus spp. and Enterobacter spp. were isolated in the same BC.
¶0 indicates that antibiotics were started on the same day but prior to sampling.CLINICAL SCIENCE 36 Croat Med J. 2012;53:30-9
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was not discriminating, as 13% of series of blood cultures 
revealed microbiological growth.
C-reactive protein and elevated white blood cells had 
low predictive values for bacteremia, while elevated pro-
calcitonin levels were correlated with positive blood cul-
ture  findings,  confirming  the  diagnostic  value  in  gen-
eral ICU settings (26) and in particular clinical scenarios 
(27,28). However, we also identified some cases of bac-
teremia with procalcitonin levels below 0.5 μg/L – a level 
only slightly above the cut-off value for ICU patients of 
0.38 μg/L (26), which further strengthens the importance 
of a cautious clinical approach. The definite diagnosis of 
sepsis might not rely on a single measurement of procal-
citonin but on a complete clinical and laboratory evalu-
ation of the patient, with procalcitonin playing a consid-
erable role.
Among the analyzed comorbid conditions, a predictor of 
positive blood culture results was liver failure. Acute and 
chronic liver diseases are known to be associated with an 
increased risk of bacteremia (29-31) and have been shown 
to be independent risk factors for the development of bac-
teremia in patients with community-acquired pneumonia 
(32). This feature has been correlated with impaired func-
tion of the hepatic reticuloendothelial system (33), and 
complement (34) and polymorphonuclear cells.
We  identified  no  associations  between  bacteremia  and 
immunodeficiency or diabetes, confirming the results of 
Grace et al (3). Interestingly, this is in contrast with the re-
sults reported by Stoeckle et al (35), who found a relative 
frequency of bloodstream infections to be more than 4 
times higher in diabetic than in non-diabetic general in-
patients.
Bacteremia was not associated with the presence of a sur-
gical wound or mechanical ventilation. All blood cultures 
obtained within 72 hours after a surgical procedure re-
mained sterile, which is in accordance with the finding that 
most early postoperative febrile episodes resolved sponta-
neously without confirmation of infection (36). Late blood 
cultures (6, 7, and 15 days after surgery) disclosed infective 
complications in only three cases. Blood cultures obtained 
from patients with mechanical ventilation had very low 
yields. This can be explained by patient selection (about 
50% were ventilated for reasons other than infection) and 
the known low sensitivity of blood cultures for disclosing 
pathogenic  microorganisms  in  ventilator-associated 
pneumonia (37).
We aimed to evaluate the utility of obtaining repeat blood 
cultures in patients receiving antibiotic therapy with new 
suspected septic episodes. Antibiotic blood cultures were 
very often negative, particularly if the pre-antibiotic blood 
culture had been negative; otherwise, the same pathogen 
was isolated as in the pre-antibiotic cultures. Nevertheless, 
in our analysis, which was not limited to the first three days 
of antibiotic therapy but included the entire ICU stay, we 
identified microorganisms not found in the pre-antibiotic 
samples in 6.5% of patients, demonstrating that this prac-
tice is not always useless and may even be very important 
for detecting either polymicrobial infections or new infec-
tion complications.
Bacteremic patients were investigated more often (ie, se-
ries of blood cultures) and with more blood cultures than 
non-bacteremic patients. However, the number of blood 
cultures drawn for each suspected septic episode was the 
same. Thus, our data do not challenge the current guide-
lines (20), which propose to limit the number of blood cul-
tures drawn per suspected septic episode to two or three. 
A  study  in  an  ICU  (38)  demonstrated  that  limitation  of 
blood cultures to up to three sets reduced the number of 
blood cultures ordered for suspected septic episodes from 
3.0 to 2.2 with no untoward effects on patient care. 
Patients  with  nosocomial  bloodstream  infections  were 
shown in one study to have a worse outcome with a lon-
ger hospital stay and an attributable mortality rate (7). Oth-
er studies (23,39-41) did not find the association of bacte-
remia with excess mortality but did with longer hospital 
stays. Our data tend to confirm the latter, as we observed 
only a trend toward longer hospital stays, while the length 
of ICU stay and mortality rates were not different between 
the bacteremic and non-bacteremic patients. Eventually, 
we cannot exclude the possibility that our study popula-
tion was too small for a meaningful assessment, as dem-
onstrated by the inconsistence of mortality, illness severity, 
and prevalence of bacteremia. SOFA and SAPS II scores dif-
fered between bacteremic and non-bacteremic patients, 
but their discriminatory capacities should be checked pro-
spectively (eg, by calculating receiver operating character-
istic curves on a larger study population).
Our study has several limitations. The retrospective obser-
vational design implies selection biases and some missing 
values (eg, for procalcitonin). Nevertheless, we attempted 
to neutralize the effects of a different number of exam-
ined septic episodes and blood cultures per septic epi-
sode by opting for a unit of observation analysis (series of 37 Previsdomini et al: Blood cultures in critically ill patients
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blood cultures) that considered all blood cultures drawn 
on a single day from one patient, which allowed us to 
adjust the impact of clinical characteristics of a given pa-
tient compared to another patient subjected to a different 
number of blood cultures. Also, data collection spanned 
over two years and the number of patients (ie, blood cul-
tures) was modest, thus limiting the power of the study. 
Although blood cultures were collected following a local 
standard operating procedure, we cannot rule out some 
technical differences. This is a critical remark, as the yields 
of blood cultures are known to increase when appropri-
ate measures are applied (eg, blood volume) (42). Triggers 
for blood culture collection were generally mentioned in 
clinical records, but we cannot exclude the possibility that 
there were more unlisted triggers. Similarly, we cannot ver-
ify how often blood cultures were not performed despite 
the presence of triggers for blood culture collection. 
In conclusion, blood cultures in a general ICU represent 
an important diagnostic tool to identify bacteremia and 
to guide diagnostic and therapeutic choices. According to 
our analysis, their rate of positivity increases with illness se-
verity (SAPS II and SOFA scores), elevated procalcitonin lev-
els, and the presence of hepatic failure, but does not seem 
to be clearly influenced by the presence of ongoing antibi-
otic therapy. Early blood cultures drawn in the presence of 
ongoing antibiotics rarely identified pathogens not found 
in the pre-antibiotic blood cultures. Therefore, the deci-
sion to perform a repeat blood culture should rely on care-
ful clinical judgment, bearing in mind that blood cultures 
drawn 4 days after an initially appropriate antibiotic ther-
apy and 6 days after surgery can detect new pathogens, 
which mainly reveal new infection complications.
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